Association for Accessible Medicines
FDANonrulemakingFDA-2019-D-5573

Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA; Draft Guidance for Industry and FDA; Availability

RIN
Last modified
Jun 24, 2020
Comment window
closed 2227d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jun 23, 2020 and Jun 23, 2020. 0 other organizations filed here. The comment window closed 2227d ago.

What Association for Accessible Medicines filed (1)

Jun 23, 2020· Comment from The Association for Accessible Medicines (AAM)· FDA-2019-D-5573-0009

Comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2019-D-5573: Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA.

Abstract

No abstract recorded.

View on regulations.gov →